• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov11
Passage Bio released FY2025 Q3 earnings on November 10 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -2.4399 (forecast USD -2.84)
04:00
Passage Bio released FY2025 9 Months Earnings on November 10 (EST), actual revenue USD 0, actual EPS USD -10.3598
04:00
Oct14
Passage Bio Announces CEO and President Transition
12:03
Aug13
Passage Bio released FY2025 Semi-Annual Earnings on August 12, 2025 (EST) with actual revenue of USD 0 and EPS of USD -7.8289
03:00
Aug12
Passage Bio released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -2.9615 (forecast USD -4.04)
15:00
Jun26
OrbiMed Advisors LLC Reports Sale of Passage Bio Inc. Common Stock
21:11

Schedules & Filings

Schedules
Filings
Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -7.749 M, EPS -2.4377

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -9.385 M, EPS -2.9615

Jul14
Reverse Stock Split(EST)

1-for-20 Reverse Stock Split

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
20.080
+197.13%
+13.322
SMX
300.000
+112.77%
+159.000
WHLR
5.839
+80.22%
+2.591
DBRG
14.510
+49.28%
+4.795
IRBT
4.335
+43.07%
+1.280
TORO
5.530
+33.90%
+1.404
LICN
3.859
+31.71%
+0.929
TDIC
0.3691
+31.45%
+0.088
RIME
1.905
+29.59%
+0.435
PRAX
246.045
+29.52%
+56.395
View More